The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Mycosis Fungoides (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Mycosis Fungoides (Oncology) - Drugs in Development, 2021 SUMMARY Mycosis Fungoides (Oncology) - Drugs in Development, 2021 provides an overview of the Mycosis Fungoides pipeline landscape. The report...
April 2021
65 pages
Myopia (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Myopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Myopia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Myopia pipeline landscape. The report provides comprehensive...
April 2021
35 pages
Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Myxoid Liposarcoma pipeline landscape. The rep...
April 2021
35 pages
Nausea (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Nausea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Nausea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Nausea pipeline landscape. The report provides compreh...
April 2021
40 pages
Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021
US$ 3,000.00
Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 SUMMARY Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Protein (NPC1) targeted pi...
April 2021
30 pages
Nonstructural Protein 1 (NS1) - Drugs in Development, 2021
US$ 3,000.00
Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 1 (NS1) targeted pipel...
April 2021
35 pages
Nonstructural Protein 3 (NS3) - Drugs in Development, 2021
US$ 3,000.00
Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 3 (NS3) targeted pipel...
April 2021
30 pages
